SEC Form 4 · accession 0001209191-15-061490
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Pellini
Officer — Chief Executive Officer · Director
Period of report
Jul 15, 2015
Accepted (ET)
Jul 17, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 15, 2015 | A | 59,365 | $32.74 | A | 164,925 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest (i) with respect to 33% of the units, on June 30, 2016, (ii) with respect to 33% of the units, on December 30, 2016, and (iii) with respect to any remaining unvested units, on June 30, 2017.